DiamiR Biosciences Corp. (DIMR)

DiamiR Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Year	Current	2023	2022
Debt / Equity Ratio	-1.97	-22.52	-2.13
Debt / EBITDA Ratio	-1.28	-0.43	-33.37
Debt / FCF Ratio	-2.42	-2.20	8.73
Quick Ratio	1.01	2.41	2.41
Interest Coverage	-11.22	-10.14	-0.94
Return on Equity (ROE)	212.95%	6515.92%	64.98%
Return on Assets (ROA)	-	-252.70%	-49.64%
Return on Capital (ROIC)	-173.40%	-265.82%	-27.86%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).